Barclays Starts Moderna (MRNA) at Overweight
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Price: $106.18 --0%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 1
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 1
Join SI Premium – FREE
Barclays analyst Gena Wang initiates coverage on Moderna (NASDAQ: MRNA) with a Overweight rating and a price target of $68.00.
For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.
Shares of Moderna closed at $56.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- JPMorgan Upgrades Dow Inc. (DOW) to Overweight
- Jefferies Upgrades Husqvarna AB (HUSQB:SS) to Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Barclays, Gena WangSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
